A critical review of outcomes of cancer during the COVID-19 pandemic
The recent outbreak of COVID-19 has created an alarming fear, apprehension, and worry world over. Cancer patients represent a subgroup that is vulnerable and is under high risk. It is, therefore, necessary to analyze factors that predict outcomes in these patients so that they can be triaged accordi...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=4;spage=461;epage=467;aulast=Sharin |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850237018358939648 |
|---|---|
| author | Florida Sharin Arjun G Singh Burhanuddin Qayyumi Pankaj Chaturvedi |
| author_facet | Florida Sharin Arjun G Singh Burhanuddin Qayyumi Pankaj Chaturvedi |
| author_sort | Florida Sharin |
| collection | DOAJ |
| description | The recent outbreak of COVID-19 has created an alarming fear, apprehension, and worry world over. Cancer patients represent a subgroup that is vulnerable and is under high risk. It is, therefore, necessary to analyze factors that predict outcomes in these patients so that they can be triaged accordingly in order to mitigate the effects of COVID-19 on cancer management. To determine the factors affecting cancer patients in COVID-19. A systematic search was performed to identify all relevant studies on PubMed, Embase, and Google Scholar published until April 5, 2020. Relevant articles that reported the incidence, demographic and clinical characteristics, treatment, and outcomes of cancer patients infected by COVID-19 were included in the analysis. Among 559 articles that were further screened, 14 articles fulfilled the inclusion criteria. The incidence of cancer across various studies ranged from 0.5% to 2.43%. Males were more than females, and the mean age affected was 63.1–66 years. Lung cancer was the most common subtype (25%–58.3%). Cancer patients, as reported, had a higher risk of progressing to severe events (hazard ratio:3.56, 95% confidence interval: 1.65–7.69; P < 0.0001). Nearly 39%–53.6% of patients who had a recent history of anticancer therapy developed severe events. Individuals with cancer feared the risk of complications. Cancer patients have worse outcomes from COVID-19, compared to the general population, providing a reason to pay more timely attention. High-risk patients should have vigorous screening and intensive surveillance. Anticancer treatment during COVID-19 should be modified based on the type and prognosis of cancer. |
| format | Article |
| id | doaj-art-33a22d5680c840a284efa5fc32b25bbb |
| institution | OA Journals |
| issn | 0971-5851 0975-2129 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-33a22d5680c840a284efa5fc32b25bbb2025-08-20T02:01:50ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292020-01-0141446146710.4103/ijmpo.ijmpo_187_20A critical review of outcomes of cancer during the COVID-19 pandemicFlorida SharinArjun G SinghBurhanuddin QayyumiPankaj ChaturvediThe recent outbreak of COVID-19 has created an alarming fear, apprehension, and worry world over. Cancer patients represent a subgroup that is vulnerable and is under high risk. It is, therefore, necessary to analyze factors that predict outcomes in these patients so that they can be triaged accordingly in order to mitigate the effects of COVID-19 on cancer management. To determine the factors affecting cancer patients in COVID-19. A systematic search was performed to identify all relevant studies on PubMed, Embase, and Google Scholar published until April 5, 2020. Relevant articles that reported the incidence, demographic and clinical characteristics, treatment, and outcomes of cancer patients infected by COVID-19 were included in the analysis. Among 559 articles that were further screened, 14 articles fulfilled the inclusion criteria. The incidence of cancer across various studies ranged from 0.5% to 2.43%. Males were more than females, and the mean age affected was 63.1–66 years. Lung cancer was the most common subtype (25%–58.3%). Cancer patients, as reported, had a higher risk of progressing to severe events (hazard ratio:3.56, 95% confidence interval: 1.65–7.69; P < 0.0001). Nearly 39%–53.6% of patients who had a recent history of anticancer therapy developed severe events. Individuals with cancer feared the risk of complications. Cancer patients have worse outcomes from COVID-19, compared to the general population, providing a reason to pay more timely attention. High-risk patients should have vigorous screening and intensive surveillance. Anticancer treatment during COVID-19 should be modified based on the type and prognosis of cancer.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=4;spage=461;epage=467;aulast=Sharincancercovid-19malignancysevere acute respiratory syndrome-related coronavirus |
| spellingShingle | Florida Sharin Arjun G Singh Burhanuddin Qayyumi Pankaj Chaturvedi A critical review of outcomes of cancer during the COVID-19 pandemic Indian Journal of Medical and Paediatric Oncology cancer covid-19 malignancy severe acute respiratory syndrome-related coronavirus |
| title | A critical review of outcomes of cancer during the COVID-19 pandemic |
| title_full | A critical review of outcomes of cancer during the COVID-19 pandemic |
| title_fullStr | A critical review of outcomes of cancer during the COVID-19 pandemic |
| title_full_unstemmed | A critical review of outcomes of cancer during the COVID-19 pandemic |
| title_short | A critical review of outcomes of cancer during the COVID-19 pandemic |
| title_sort | critical review of outcomes of cancer during the covid 19 pandemic |
| topic | cancer covid-19 malignancy severe acute respiratory syndrome-related coronavirus |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=4;spage=461;epage=467;aulast=Sharin |
| work_keys_str_mv | AT floridasharin acriticalreviewofoutcomesofcancerduringthecovid19pandemic AT arjungsingh acriticalreviewofoutcomesofcancerduringthecovid19pandemic AT burhanuddinqayyumi acriticalreviewofoutcomesofcancerduringthecovid19pandemic AT pankajchaturvedi acriticalreviewofoutcomesofcancerduringthecovid19pandemic AT floridasharin criticalreviewofoutcomesofcancerduringthecovid19pandemic AT arjungsingh criticalreviewofoutcomesofcancerduringthecovid19pandemic AT burhanuddinqayyumi criticalreviewofoutcomesofcancerduringthecovid19pandemic AT pankajchaturvedi criticalreviewofoutcomesofcancerduringthecovid19pandemic |